Acetylcholine receptor |
Rare mothers with antibodies that inhibit fetal AChR, paralyze baby in utero, and cause multiple fixed joints, with paralysis and death ex utero
|
Maternal plasma antibodies injected into dams during E13–18 of pregnancy. Proportion of offspring who died at birth or shortly after probably due to lack of respiration |
Antibodies present in mouse offspring, offspring showed fixed joints mirroring changes in human babies |
(36) |
CASPR2 |
4.9% of mothers with children diagnosed with range of motor and psychological disorders, not autism. HC 0.9% |
IgG purified from plasmapheresis samples of two CASPR2-Ab-positive patients. Mice showed changes in cognition and impaired social interactions |
Long-term neuropathological changes with activated microglia and glutamatergic synaptic loss |
(121, 122) |
CASPR2 |
37% of selected (brain reactive Abs) mothers of children with autism spectrum disorder; 12% of unselected women of childbearing age |
MAb binding CASPR2 cloned from the mother of an autistic child. Mice showed impairments in sociability, flexible learning, and repetitive behaviors |
Abnormal cortical development, decreased dendritic complexity of excitatory neurons, and reduced numbers of inhibitory neurons in the hippocampus |
(123) |
NMDAR (NR1 subunit) |
Marginal evidence for NMDAR antibodies in mothers of children with any psychiatric/neuropsychiatric disorders |
mAbs from NMDAR-Ab-positive women. Mice showed early postnatal mortality (27.2%), altered blood pH, and impaired neurodevelopmental reflexes. Ex vivo, NMDAR reduced in brain, with altered spontaneous excitatory postsynaptic currents. When adult, persistent hyperactivity, lower anxiety, and impaired sensorimotor gating |
NMDAR was reduced (up to 49.2%), and electrophysiological properties were altered, reflected by decreased amplitudes of spontaneous excitatory postsynaptic currents in young neonates (−34.4%). Cerebellum, midbrain, brain stem volumes reduced |
(124) |